• 한국가축번식학회지
• /
• 제14권3호
• /
• pp.213-221
• /
• 1990

This study was conducted to find out the changes of progesterone and estrone sulphate concentration in serum of Korean native goats throughout gestation, and to apply the serum levels of the hormones to pregnancy diagnosis. Serum concentration of progesterone and estrone sulphate were assayed by radioimmunoassay. Serum progesterone concentration was similar to its luteal phase values during early pregnancy and remained at the high level continually at 20∼140days and decreased rapidly at the day of parturition. Serum estrone sulphate concentration showed to increase markedly at 40∼50dyas gestation and steadily increased to the maximum of 7.13ng/ml at 140days, but declined sharply at the day of parturition. The accuracy of pregnancy diagnosis by the measurement of serum progesterone at 20∼24days after mating was 85.7∼92.3% and that of non-pregnancy diagnosis was 100%, when the serum progesterone levels higher and lower than 3.0ng/ml were supposed to indicate pregnancy and non-pregnancy, respectively. The accuracy of pregnancy diagnosis by the mearsurement of serum estrone sulphate was found to be nearly 100% since 50days after mating, when the serum levels of estrone sulphate higher then 0.5ng/ml were diagnosed to be pregnant. The optimal sampling time for pregnancy diagnosis was considered to be at 50 days after mating or to be later. It appears that estrone sulphate values above 7.0ng/ml at any time in gestation are highly indicative of twin. But there was found no significant difference(P<0.05) in serum estrone sulphate concentration and number of kids between does with single and twin kids.

• Clinical and Experimental Reproductive Medicine
• /
• 제37권2호
• /
• pp.153-158
• /
• 2010

목 적: 과배란유도 후 자궁강내 인공수정 시술시 황체기 보강으로서 경구 미분화 프로게스테론 투여법과 경구 디드로게스테론 투여법의 임상적 효용성을 비교하고자 하였다. 연구방법: 2007년 1월부터 2009년 8월까지 시행된 과배란유도 후 자궁강내 인공수정 시술 183주기를 후향적으로 분석하였다. 과배란유도는 성선자극호르몬 단독 또는 클로미펜과 성선자극호르몬의 병합요법을 사용하였다. 136주기에서는 황체기 보강으로서 경구 미분화 프로게스테론을 하루 300 mg으로 투여하였고 47주기에서는 디드로게스테론을 일일 20 mg으로 투여하였다. 결 과: 여성의 연령, 불임 인자, 성숙난포수 ($\geq$16 mm), 총운동성정자수, triggering 날의 자궁내막 두께는 두 군간 유의한 차이가 없었다. 자궁내 태낭이 확인되는 임상적 임신율은 미분화 프로게스테론 투여군에서 21.3%, 디드로게 스테론 투여군에서 19.1%로 차이가 없었다 (p=0.92). 유산율은 미분화 프로게스테론 투여군에서 다소 높은 경향을 보였으나 통계학적인 차이는 없었다 (34.5% vs. 11.1%, p=0.36). 결 론: 황체기 보강으로서 경구 디드로게스테론 투여법은 경구 미분화 프로게스테론 투여에 비하여 비슷한 임신율과 유산율을 보였다. 그러나 상대적으로 디드로게스테론 투여군의 수가 적어 좀더 많은 환자를 대상으로 한 전향적 연구가 필요하다.

• 한국수정란이식학회지
• /
• 제32권3호
• /
• pp.159-163
• /
• 2017

The artificial insemination (AI) is one of the best assisted reproductive technologies for increasing reproductive capacity and facilitating the genetic improvement in farm animals. AI has been used in Uganda for over 60 years, but a small population of the total herd has been used. This study was conducted to investigate the efficacy of AI with estrus synchronization technique and to propose ways of improving the productivity of dairy farms through AI services in Uganda. In total, 78 cows from 11 dairy farms were selected for timed-AI. Synchronization was performed according to the ovsynch programs followed by AI using frozen semen from Korean Holstein (0.5 ml straws). Pregnancy rate was varying among farms (0-50%) and the overall pregnancy rate was 28.2%. Cows in luteal phase at the time of treatment was 40.0% whereas that in follicular phase was 20.8%. After treatment, cows that showed normal estrus signal were 45.5% (25/55). Abnormal estrus was categorized into pre-estrus (9.1%), cystic ovaries (21.8%), anestrus (18.2%) and delayed ovulation (5.5%), respectively. These results imply that an assured protocol for timed-AI should be developed to improve the productivity of dairy farms through AI services in Uganda.

• Asian-Australasian Journal of Animal Sciences
• /
• 제25권11호
• /
• pp.1540-1545
• /
• 2012

Steroidogenesis requires coordination of the anabolic and catabolic pathways of lipid metabolism, but the profile of proteins associated with progesterone synthesis in cyclic and pregnant corpus luteum (CL) is not well-known in cattle. In Experiment 1, plasma progesterone level was monitored in cyclic cows (n = 5) and pregnant cows (n = 6; until d-90). A significant decline in the plasma progesterone level occurred at d-19 of cyclic cows. Progesterone level in abbatoir-derived luteal tissues was also determined at d 1 to 5, 6 to 13 and 14 to 20 of cyclic cows, and d-60 and -90 of pregnant cows (n = 5 each). Progesterone level in d-60 CL was not different from those in d 6 to 13 CL and d-90 CL, although the difference between d 6 to 13 and d-90 was significant. In Experiment 2, protein expression pattern in CL at d-90 (n = 4) was compared with that in CL of cyclic cows at d 6 to 13 (n = 5). Significant changes in the level of protein expression were detected in 32 protein spots by two-dimensional polyacrylamide gel electrophoresis (2-DE), and 23 of them were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Six proteins were found only in pregnant CL, while the other 17 proteins were found only in cyclic CL. Among the above 6 proteins, vimentin which is involved in the regulation of post-implantation development was included. Thus, the protein expression pattern in CL was disorientated from cyclic luteal phase to mid pregnancy, and alterations in specific CL protein expression may contribute to the maintenance of pregnancy in Korean native cows.

• Clinical and Experimental Reproductive Medicine
• /
• 제12권2호
• /
• pp.15-23
• /
• 1985

Therapy for anovulation represents one of the more gratifying and successful type of infertility management. Despite the introduction of bromocriptine, human menopausal gonadotropin (HMG), and gonadotropin releasing hormone (GnRH), clomiphene citrate remains the mainstay of ovulation induction therapy. There is wide variability in reported rates of ovulation induction (57-91%) and conception (25-43%) following clomiphene therapy. Factors contributing to this variability among different reports are the differences in dosage and duration of therapy, different criteria utilized in selecting patients for clomiphene therapy and different luteal phase parameters of presumptive ovulation. A review of recent experience with clomiphene citrate in the Department of Obstetrics and Gynecology in Seoul National University from January, 1983 to May, 1985 yields the following conclusions: 1. Ovulation rate per total patients treated was, 69.0% 2. Pregnancy rate per total patients treated was 31.7%, and that per total patients ovulated was 45.9%. 3. Ovulation rate at the dosage level up to 150 mg/day (50.3-53.8%) was somewhat higher than that at 200 mg/day or more (33.3-34.6%), and pregnancy rate per total patients treated was comparable at each dosage level. 4. Ovulation rate per total patients ovulated at each dosage level, where ovulation and conception occurred, showed a decreasing tendency as the dosage increased, but pregnancy rate per total patients conceived was comparable except at 200 mg/day. 5. Cumulative pregnancy rate per total patients conceived in each ovulatory cycle was 68.9% in 3 cycles, 88.9% in 4 cycles, and 100% in 6 cycles.

• Clinical and Experimental Reproductive Medicine
• /
• 제39권1호
• /
• pp.22-27
• /
• 2012

Objective: To evaluate the effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase (MDP-EL) in comparison with standard GnRH agonist luteal long protocol (LP) in each non-obese and obese polycystic ovary syndrome (PCOS) women undergoing IVF. Methods: Two hundred eleven infertile women with PCOS were recruited and randomized to undergo either GnRH antagonist MDP-EL (antagonist group) or standard GnRH agonist luteal LP (agonist group). IVF cycle outcomes were compared between the two groups. Results: Total dose and days of recombinant human follicle stimulating hormone (rhFSH) administered were significantly fewer in the antagonist group than in the agonist group. Incidence of severe ovarian hyperstimulation syndrome was significantly lower in the antagonist group. However, IVF and pregnancy outcomes were similar in the two groups. When all subjects were divided into non-obese and obese subgroups, in non-obese PCOS subgroup, IVF and pregnancy outcomes were comparable in the antagonist and agonist groups but total dose and days of rhFSH were also significantly fewer in the antagonist group. Similar findings were also observed in obese PCOS subgroup. Conclusion: GnRH antagonist MDP-EL is at least as effective as GnRH agonist LP and may be a more patient-friendly alternative in controlled ovarian stimulation for PCOS patients undergoing IVF, independent of body mass index.

• Clinical and Experimental Reproductive Medicine
• /
• 제12권1호
• /
• pp.47-70
• /
• 1985

This study was presented of the 1,872 cases of infertile couples who visited and examined at the sterility clinic of Department of Obstetrics & Gynecology, Seoul National University Hospital from Sept., 1980 to Dec., 1983. Age, duration of infertility, past medical history, and other general factors were analyzed, and the factors responsible for infertility were classified and discussed. Mode of treatment, outcome of pregnancy, pregnancy rate responsible for each factor were also presented. The results were as follows: 1) The infertility was primary in 1,128, or 60.3% and secondary in 744, or 39.7%. 2) The age between 26 and 30 years of age comprised about one half of the total patients. 3) The duration of infertility between 1 and 4 years comprised about three quarters of the total patients, and the mean duration was 3.8 years. 4) The most common medical history in primary infertility was tuberculous disease, and that in secondary infertility was history of previous laparotomy. 5) About two thirds of antecedent pregnancies were abortion. 6) The major etiologic factor of infertility were male factor in 12.3%, tubal factor in 38.8%, ovulatory failure in 25.4%, uterine factor in 8.8%, cervical factor in 5.2%, peritoneal factor in 9.5%, and no demonstrable cause in 11.3%. 7) The types of male factor were azoospermia in 61.6%, oligospermia in 25.8%, low motility in 11.6%, and other abnormality in 1.0%. 8) The types of ovulatory failure were ovarian failure in 7.4%, hypothalamo-pituitary failure in 8.1 %, hypothalamo-pituitary dysfunction (including Polycystic ovarian syndrome) in 30.2%, and hyperprolactinemia in 22.4%. 9) The types of uterine factor were endometrial tuberculosis in 27.5%, uterine synechia in 33.8%, uterine anomaly in 19.7%, myoma and polyp in 9.1 %, and luteal phase defect in 9.9%. 10) The types of peritoneal factor were pelvic adhesion in 80.9% and endometriosis in 19.6%. 11) Surgeries were done in 408 patients, and they were salpingolysis, lysis of extraadnexal adhesion, salpingostomy, fimbrioplasty, ovarian wedge resection for polycystic ovarian disease, tubo-tubal anastomosis, and tubo-uterine implantation in orders. 12) 243 pregnancies were achieved during the infertility work-up, of which livebirth was 46.5%, ectopic pregnancy was 7.4%, spontaneous abortion was 7.8%, and on-going pregnancy or lost to follow-up was 36.2%. 13) Pregnancy rates in various factors were male factor in 18.7%, ovulatory factor in 31.7%, tubal factor in 24.2%, uterine factor in 34.6%, cervical factor in 19.0%, peritoneal factor in 29.0%, combined factors in 10.5%, and unexplained infertility in 37.1%. Pregnancy rate in whole patients was 25.2%.

• 한방비만학회지
• /
• 제7권1호
• /
• pp.31-38
• /
• 2007

Objective : Women's obesity brings prblems not only appearance but also health which men do not have. This study was conducted to investigate the different factors of obesity between men and women. Materials and Methods : We searched papers usin key words (women, gender, and obesity) on pubmed and obesity journal. Result : Women's obesity leads to amenorrhea, abnormal uterine bleeding, infertility, poly cystic ovarian syndrome, abortion, and luteal phase inadequacy. Obesity induces metabolic syndrome, type-2 diabetes, cardiovascular problems, hypertension, cancer, and psychophysiologic diseases. The difference in body morphology and in particular fat distribution between the sexes leads to gender-specific differences in prevalence of chronic diseases, and unique problems for each sex including infertility, problems during pregnancy, polycystic ovarian syndrome, and endometrial carcinoma in women, and prostate and testicular cancer in men. The influence of gender on obesity is had by genetic view, hormones, pregnancy, delivery, and menopause. Conclusion : Obese women have higher risk factors than men by the influence of gender.

• 농업과학연구
• /
• 제11권2호
• /
• pp.233-243
• /
• 1984

본(本) 연구(硏究)는 Landrace순종(純種)의 미경산돈(未經산豚) 6두(頭)를 가지고 발정주기(發情週期) 및 임신기간(妊娠期間)동안의 혈청중(血淸中) 성(性) hormone수준(水準)의 변화(變化)를 구명(究明)하기 위하여 실시(實施)하였으며, 이정맥(耳靜脈)에서 혈액(血液)을 채취(採取)하여 혈청(血情)을 분리(分離)한 다음, 이를 시료(試料)로 하여 LH, FSH, prolactin, progesterone, $estradiol-17{\beta}$ 및 cortisol을 radioimmunoassay 방법(方法)으로 분석(分析)하였는바, 그 결과(結果)를 요약(要約)하면 다음과 같다. 1. Landrace순종(純種) 미경산돈(未經産豚)의 성성숙도달일령(性成熟到達日齡)은 179.5일(日), 성성숙도달체중(性成熟到達體重)은 88.2kg, 발정주기(發情週期) 21.3일(日), 임신기간(妊娠期間)은 114일(日)이었고, 복당산자수(腹當산仔數)는 9.5두(頭)였다. 2. 발정주기중(發情週期中)의 LH농도(濃度)는 1.56mIU/ml 이하(以下), prolactin 농도(濃度)는 2.4ng/ml 이하(以下)로 분석한계수준이하(分析限界水準以下)였다. FSH농도(濃度)는 발정열시후(發情閱始後) 6일(日)부터 15일(日)까지 1.50~2.20 mIU/ml 범위(範圍)였으며, 발정시(發情時)와 발정전후(發情前後) 3일(日)에는 1.25 mIU/ml 이하(以下)였다. 3. 발정주기중(發情週期中)의 progesterone 농도(濃度)는 발정일(發情日)에 1.90ng/ml를 나타냈으나, 발정열시후(發情閱始後) 3일(日)에 13.10ng/ml 증가(增加)하였고 9일(日)에 최고수준(最高水準)에 도달(到達)하였다. $Estradiol-17{\beta}$농도(濃度)는 발정일(發情日)과 발정개시후(發情開始後) 18일(日)에 27.2pg/ml을 나타냈고, 그밖의 기간(期間)에서는 27.2pg/ml 이하(以下)였다. Cortisol 농도(濃度)는 발정일(發情日)에 최고수준(最高水準)에 도달(到達)했으며, 황체기(黃體期)동안에는 24.65~28.57ng/ml 범위(範圍)에 있었다. 4. 임신기간중(姙娠期間中)의 LH농도(濃度)는 3.10~4.37 mIU/ml, FSH농도(濃度)는 1.30~1.80 mIU/ml, 그리고 prolactin 농도(濃度)는 2.60~6.70ng/ml의 범위(範圍)를 나타냈다. 5. Progesterone 농도(濃度)는 전임신기간(全姙娠期間)에 38.90~16.85ng/ml 범위(範圍)에 있었으나 분만시(分娩時)에는 1.96ng/ml로 급격(急激)히 감소(減少)하였다. $Estradiol-17{\beta}$의 농도(濃度)는 임신후(姙娠後) 15일(日)에 27.2pg/ml을 나타냈으며, 그후 계속(繼續) 증가(增加)하여 분만시(分娩時)는 620.17pg/ml을 나타냈다. Cortisol 농도(濃度)는 전임신기간(全姙娠期間)에 걸쳐 13.58~24.35ng/ml의 범위(範圍)를 나타냈다.

• Reproductive and Developmental Biology
• /
• 제30권3호
• /
• pp.213-218
• /
• 2006

본 연구는 젖소의 분만 후 난소 주기 재개의 이상이 번식 성적에 미치는 영향을 구명하기 위해 수행하였다. 정상적인 난소 주기가 진행이 되면 배란된 날에 난소 주기가 재개된 것으로 간주하였다. 공시우의 58.8%(l14/194)가 정상적인 난소 주기의 재개를 하였고 41.2%의 소에서 난소 주기의 재개가 지연되었다. 배란 후 황체기가 20일 이상 유지되는 난소 주기의 재개지연 I형(17.5%)과 분만 후 40일 이전에 첫 배란이 나타나지 않는 난소 주기의 재개지연 II형(22.7%)이 난소 주기 재개 지연의 일반적인 형태였다. 정상적인 난소 주기를 가진 개체와 비교해 보면, 황체기가 연장된 소들의 분만 후 100일 이내의 인공수정 공시율, 수태율과 임신율은 더 낮고(각각 84.2 대 40.0%; p<0.01, 24.0 대 21.4%, 20.2 대 11.1%) 분만 후 첫 수정 일수와 공태 일수가 더 길다(각각 $64.7{\pm}2.79$ 대 $105.7{\pm}7.48$일; p<0.01, $105.1{\pm}7.16$ 대 $133.7{\pm}11.17$일). 정상우와 무배란우를 비교해 보면, 100일 이내의 수태율과 임신율이 낮고(각각 24.0대 20.0%, 20.2 대 16.3%) 분만 후 첫 수정 일수과 공태 일수가 더 길다(각각 $64.6{\pm}2.79$ 대 $72.6{\pm}4.45$일, $105.1{\pm}7.16$ 대 $120.8{\pm}12.33$일). 결론적으로 젖소의 분만 후 비정상적인 난소 주기는 인공수정 공시율, 임신율, 첫 수정 일수와 공태 기간을 포함하는 번식 성적의 저하를 유발시킨다.